30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Kevin Conroy

Track

Insider profile

Currently holds positions in Exact Sciences Corp, Epizyme Inc and Genomic Health Inc

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return 19% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, President, Chief Executive Officer Exact Sciences Corp March 21, 2014 -
Independent Director Epizyme Inc Feb. 6, 2017 -
President Genomic Health Inc Nov. 8, 2019 -
President, Chief Executive Officer, Director Exact Sciences Corp April 2, 2009 - March 21, 2014
Kevin Conroy's trades of Exact Sciences Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-13 2024-11-13
B Purchase
78,003 -31.5%
157.93
US$1,155,503 		78,003 -31.5% 157.93 US$1,155,503
2024-05-02 2024-05-01
PlS Planned sale
37,782 +30.7%
243.07
US$560,745 		37,782 +30.7% 243.07 US$560,745
2024-05-02 2024-05-01
PlS Planned sale
42,290 -43.0%
259.52
US$718,276 		42,290 -43.0% 259.52 US$718,276
2024-05-01 2024-05-01
PrS Proposed sale
1,155
60.15
US$69,473 		1,155 60.15 US$69,473
2024-03-04 2024-03-01
PlS Planned sale
8,271 -0.6%
59.32
US$490,636 		8,271 -0.6% 59.32 US$490,636
2024-03-01 2024-03-01
PrS Proposed sale
8,271
59.32
US$490,628 		8,271 59.32 US$490,628
2024-02-28 2024-02-27
PlS Planned sale
6,263 -0.5%
56.89
US$356,302 		6,263 -0.5% 56.89 US$356,302
2024-02-27 2024-02-27
PrS Proposed sale
6,263
56.89
US$356,325 		6,263 56.89 US$356,325
2024-02-23 2024-02-22
PlS Planned sale
11,565 -0.9%
59.78
US$691,356 		11,565 -0.9% 59.78 US$691,356
2024-02-22 2024-02-22
PrS Proposed sale
11,565
59.77
US$691,297 		11,565 59.77 US$691,297
2024-02-22 2024-02-21
PlS Planned sale
4,975 -0.4%
61.50
US$305,962 		4,975 -0.4% 61.50 US$305,962
2024-02-21 2024-02-21
PrS Proposed sale
4,975
61.50
US$305,973 		4,975 61.50 US$305,973
2024-02-16 2024-02-15
PlS Planned sale
14,791 -1.2%
61.43
US$908,611 		14,791 -1.2% 61.43 US$908,611
2024-02-15 2024-02-15
PrS Proposed sale
14,791
61.43
US$908,608 		14,791 61.43 US$908,608
2023-03-01 2023-02-28
PlS Planned sale
10,416 -0.9%
61.12
US$636,626 		10,416 -0.9% 61.12 US$636,626
2023-02-23 2023-02-22
PlS Planned sale
4,764 -0.4%
62.72
US$298,798 		4,764 -0.4% 62.72 US$298,798
2023-02-16 2023-02-15
PlS Planned sale
14,617 -1.2%
65.59
US$958,729 		14,617 -1.2% 65.59 US$958,729
2023-02-14 2023-02-13
PlS Planned sale
4,527 -0.4%
64.55
US$292,218 		4,527 -0.4% 64.55 US$292,218
2022-07-06 2022-07-01
PlS Planned sale
7 -0.0%
40.75
US$285 		7 -0.0% 40.75 US$285
2022-03-02 2022-03-01
PlS Planned sale
14,299 -1.5%
76.69
US$1,096,590 		14,299 -1.5% 76.69 US$1,096,590
2022-02-25 2022-02-24
PlS Planned sale
27,126 -2.9%
70.10
US$1,901,533 		27,126 -2.9% 70.10 US$1,901,533
2022-02-24 2022-02-23
PlS Planned sale
5,188 -0.6%
69.05
US$358,231 		5,188 -0.6% 69.05 US$358,231
2022-02-16 2022-02-15
PlS Planned sale
14,409 -1.6%
79.55
US$1,146,236 		14,409 -1.6% 79.55 US$1,146,236
2021-11-03 2021-11-01
PlS Planned sale
16,922 -2.5%
93.88
US$1,588,637 		16,922 -2.5% 93.88 US$1,588,637
2021-10-05 2021-10-01
PlS Planned sale
17,078 -2.4%
93.64
US$1,599,184 		17,078 -2.4% 93.64 US$1,599,184
2021-06-03 2021-06-01
PlS Planned sale
12,384 -1.6%
111.00
US$1,374,624 		12,384 -1.6% 111.00 US$1,374,624
2021-05-05 2021-05-03
PlS Planned sale
19,240 -2.5%
131.09
US$2,522,172 		19,240 -2.5% 131.09 US$2,522,172
2021-03-03 2021-03-02
PlS Planned sale
9,796 -1.2%
138.42
US$1,355,962 		9,796 -1.2% 138.42 US$1,355,962
2021-03-02 2021-03-01
PlS Planned sale
26,958 -3.3%
136.79
US$3,687,585 		26,958 -3.3% 136.79 US$3,687,585
2021-03-02 2021-03-01
PlS Planned sale
4,335 -0.5%
137.44
US$595,802 		4,335 -0.5% 137.44 US$595,802
2021-02-25 2021-02-24
PlS Planned sale
16,420 -2.0%
136.30
US$2,238,046 		16,420 -2.0% 136.30 US$2,238,046
2021-02-18 2021-02-17
PlS Planned sale
15,825 -2.0%
142.66
US$2,257,594 		15,825 -2.0% 142.66 US$2,257,594
2021-02-03 2021-02-01
PlS Planned sale
30,344 -3.8%
138.07
US$4,189,596 		30,344 -3.8% 138.07 US$4,189,596
2021-01-07 2021-01-04
PlS Planned sale
31,814 -3.7%
128.74
US$4,095,734 		31,814 -3.7% 128.74 US$4,095,734
2020-12-02 2020-12-01
PlS Planned sale
100 -0.0%
126.59
US$12,659 		100 -0.0% 126.59 US$12,659
2020-12-02 2020-12-01
PlS Planned sale
100 -0.0%
126.49
US$12,649 		100 -0.0% 126.49 US$12,649
2020-12-02 2020-12-01
PlS Planned sale
7,043 -0.8%
125.92
US$886,855 		7,043 -0.8% 125.92 US$886,855
2020-12-02 2020-12-01
PlS Planned sale
10,840 -1.2%
124.88
US$1,353,699 		10,840 -1.2% 124.88 US$1,353,699
2020-12-02 2020-12-01
PlS Planned sale
7,776 -0.9%
124.03
US$964,457 		7,776 -0.9% 124.03 US$964,457
2020-12-02 2020-12-01
PlS Planned sale
2,918 -0.3%
122.91
US$358,651 		2,918 -0.3% 122.91 US$358,651
2020-12-02 2020-12-01
PlS Planned sale
1,800 -0.2%
122.05
US$219,690 		1,800 -0.2% 122.05 US$219,690
2020-11-03 2020-11-02
PlS Planned sale
400 -0.0%
124.71
US$49,884 		400 -0.0% 124.71 US$49,884
2020-11-03 2020-11-02
PlS Planned sale
600 -0.1%
123.45
US$74,070 		600 -0.1% 123.45 US$74,070
2020-11-03 2020-11-02
PlS Planned sale
9,577 -1.1%
122.33
US$1,171,554 		9,577 -1.1% 122.33 US$1,171,554
2020-11-03 2020-11-02
PlS Planned sale
10,229 -1.1%
121.52
US$1,243,028 		10,229 -1.1% 121.52 US$1,243,028